[Delayed diagnosis: inevitable fatality or wrong methodological approach? Churg-Strauss syndrome].
A case of CSS is reviewed, along its difficult diagnosis, to check if its late discovery is attributed to inevitability or to erroneous approach.
Labbadia
G
G
Istituto di Terapia Medica, Università degli Studi di Roma La Sapienza.
Paoletti
V
V
Mammarella
A
A
Leone
G
G
Pacelli
M
M
Musca
A
A
D015267:Churg-Strauss Syndrome / Q000175:diagnosis* / Q000188:drug therapy / Q000276:immunology / Q000473:pathology; D003520:Cyclophosphamide / Q000627:therapeutic use; D003937:Diagnosis, Differential; D003951:Diagnostic Errors; D005260:Female; D006801:Humans; D017681:Hypereosinophilic Syndrome / Q000175:diagnosis*; D006942:Hypergammaglobulinemia / Q000175:diagnosis / Q000276:immunology; D008875:Middle Aged; D012867:Skin / Q000000981:diagnostic imaging; D013997:Time Factors; D014221:Triamcinolone / Q000627:therapeutic use; D014463:Ultrasonography; D014657:Vasculitis / Q000145:classification / Q000473:pathology
D014221:Triamcinolone; D003520:Cyclophosphamide
La diagnosi tardiva: una inevitabile fatalità o un errato approccio metodologico? La sindrome di Churg-Strauss.